Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection.
Clark
K R
KR
Transplant Unit, Royal Victoria Infirmary, Newcastle Upon Tyne, England.
Forsythe
J L
JL
Shenton
B K
BK
Lennard
T W
TW
Proud
G
G
Taylor
R M
RM
D015703:Antigens, CD / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D017252:CD3 Complex; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000627:therapeutic use; D005434:Flow Cytometry / Q000379:methods; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell / Q000032:analysis; D012189:Retrospective Studies; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D016896:Treatment Outcome; D006113:United Kingdom
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D000961:Antilymphocyte Serum; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine